AGNC vs LAMR

AGNC exhibits severe financial health concerns, as evidenced by a Piotroski F-Score of 3/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises unquantified distress risk. Despite a high intrinsic value estimate of $43.37 and a Graham Number of $17.64, the stock trades at $10.23, suggesting a potential undervaluation—however, this is undermined by extreme leverage (Debt/Equity: 6.89), near-zero liquidity (Current Ratio: 0.18), and a 97.96% payout ratio. The recent insider selling of $11.43M over six months signals strong bearish sentiment, while earnings have consistently missed expectations in the last four quarters. The 52-week range of $7.85–$12.19 reflects high volatility and lack of sustained momentum.

LAMR exhibits significant valuation misalignment, trading at a massive premium to its Graham Number ($35.97) and Intrinsic Value ($40.32). While the Piotroski F-Score of 4/9 indicates stable health, the financial profile is marred by a dangerous payout ratio of 107.45% and a low current ratio of 0.58. Consistent earnings misses (0/4 in the last year) combined with a bearish technical trend (10/100) and insider selling suggest a lack of fundamental support for the current price level.